Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Jeng Tai

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Integrative Cancer Therapies|July 18, 2012
Effectiveness of 3-week intervention of Shi Quan Da Bu Tang for alleviating hematotoxicity among patients with breast carcinoma receiving chemotherapySheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
Cancer Biology & Therapy|September 23, 2009
Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanismJeng-Fong Chiou, Cheng-Jeng Tai, Yu-Huei Wang, et al.
Cancer Nursing|October 11, 2012
A comparative study of symptoms and quality of life among patients with breast cancer receiving target, chemotherapy, or combined therapySheng-Miauh Huang, Chen-Jei Tai, Kuan-Chia Lin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage II or III breast cancerCheng-Jeng Tai, Chin-Kwun Pan, Ching-Shyang Chen, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 11, 2013
Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug TherapiesSheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
International Journal of Colorectal Disease|February 25, 2014
Clinical outcomes of robot-assisted intersphincteric resection for low rectal cancer: comparison with conventional laparoscopy and multifactorial analysis of the learning curve for robotic surgeryLi-Jen Kuo, Yen-Kuang Lin, Chun-Chao Chang, et al.
Complementary Therapies in Medicine|April 8, 2015
Effects of symptoms and complementary and alternative medicine use on the yang deficiency pattern among breast cancer patients receiving chemotherapySheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 7, 2014
The Effect of Mushroom Beta-Glucans from Solid Culture of Ganoderma lucidum on Inhibition of the Primary Tumor MetastasisShiu-Nan Chen, Ching-Sheng Chang, Ming-Hsin Hung, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2015
Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancerChien-Yu Huang, Yu-Jia Chang, Sheng-Dean Luo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 2016
Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinomaPo-Li Wei, Chien-Yu Huang, Cheng-Jeng Tai, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Integrative Cancer Therapies|July 18, 2012
Effectiveness of 3-week intervention of Shi Quan Da Bu Tang for alleviating hematotoxicity among patients with breast carcinoma receiving chemotherapySheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
Cancer Biology & Therapy|September 23, 2009
Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanismJeng-Fong Chiou, Cheng-Jeng Tai, Yu-Huei Wang, et al.
Cancer Nursing|October 11, 2012
A comparative study of symptoms and quality of life among patients with breast cancer receiving target, chemotherapy, or combined therapySheng-Miauh Huang, Chen-Jei Tai, Kuan-Chia Lin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage II or III breast cancerCheng-Jeng Tai, Chin-Kwun Pan, Ching-Shyang Chen, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 11, 2013
Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug TherapiesSheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
International Journal of Colorectal Disease|February 25, 2014
Clinical outcomes of robot-assisted intersphincteric resection for low rectal cancer: comparison with conventional laparoscopy and multifactorial analysis of the learning curve for robotic surgeryLi-Jen Kuo, Yen-Kuang Lin, Chun-Chao Chang, et al.
Complementary Therapies in Medicine|April 8, 2015
Effects of symptoms and complementary and alternative medicine use on the yang deficiency pattern among breast cancer patients receiving chemotherapySheng-Miauh Huang, Li-Yin Chien, Cheng-Jeng Tai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 7, 2014
The Effect of Mushroom Beta-Glucans from Solid Culture of Ganoderma lucidum on Inhibition of the Primary Tumor MetastasisShiu-Nan Chen, Ching-Sheng Chang, Ming-Hsin Hung, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2015
Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancerChien-Yu Huang, Yu-Jia Chang, Sheng-Dean Luo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 2016
Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinomaPo-Li Wei, Chien-Yu Huang, Cheng-Jeng Tai, et al.
Pageof 9